Inhibition of catecholamine and 5-hydroxytryptamine induced enzyme secretion from the guinea-pig submandibular gland by 2-bromo-d-lysergic acid diethylamide.
D000681:Amylases / Q000378:metabolism*; D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D002395:Catecholamines / Q000037:antagonists & inhibitors*; D004298:Dopamine / Q000494:pharmacology; D018492:Dopamine Antagonists; D004837:Epinephrine / Q000494:pharmacology; D006168:Guinea Pigs; D008238:Lysergic Acid Diethylamide / Q000494:pharmacology*; D008297:Male; D009638:Norepinephrine / Q000494:pharmacology; D010544:Peroxidases / Q000378:metabolism*; D011955:Receptors, Drug; D012636:Secretory Rate / Q000187:drug effects; D012701:Serotonin / Q000494:pharmacology; D013363:Submandibular Gland / Q000187:drug effects* / Q000201:enzymology; D013806:Theophylline / Q000494:pharmacology
D002395:Catecholamines; D018492:Dopamine Antagonists; D011955:Receptors, Drug; D012701:Serotonin; D003994:Bucladesine; D008238:Lysergic Acid Diethylamide; D013806:Theophylline; D010544:Peroxidases; D000681:Amylases; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine